The landscape of dementia diagnosis has advanced drastically with the arrival of subtle biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent assessments which can detect Alzheimer's pathology many years just before indicators arise. When these technological innovations stand for outstanding progress in knowing neurodegener